Vaccines for neglected diseases: challenges and opportunities
2011
Vaccines for Neglected Diseases: Challenges and Opportunities
publication
Author Information
Author(s): Saul Allan
Primary Institution: Novartis Vaccines Institute for Global Health
Conclusion
New vaccines for neglected diseases require innovative scientific solutions and collaboration between scientific institutes, public financing, and industry.
Supporting Evidence
- 99% of the global burden of infectious diseases is in low and middle income countries.
- Diarrheal and respiratory diseases are the most pressing issues for children in these regions.
- Current funding priorities do not match the burden of these diseases.
Takeaway
There are many diseases in poor countries that don't have vaccines, and we need new ways to create them with help from scientists and companies.
Want to read the original?
Access the complete publication on the publisher's website